{
    "clinical_study": {
        "@rank": "112666", 
        "arm_group": [
            {
                "arm_group_label": "Acetaminophen", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Tinospora Crispa-extract Product", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen.\n\n      This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product\n      compared with the acetaminophen. Total of 96 patients with body temperature between\n      37.8-38.5 without any signs of infections will be enrolled in this study. Patients will be\n      randomly divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr,\n      Second group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third\n      group will receive placebo twice daily."
        }, 
        "brief_title": "Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Patients With Body Temperature Between 37.8-38.5", 
            "No Sign of Infection", 
            "No Liver and Kidney Problem"
        ], 
        "detailed_description": {
            "textblock": "Patients in each group will be monitored for body temperature at baseline (at the time of\n      enrollment) and at 1, 2, 4, 6, 8, 24 h after receiving the tested material."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age over 18 years old\n\n          -  Body temperature between 37.8-38.5\n\n          -  Body weight not less than 40 kg but not over 100 kg\n\n          -  Liver enzymes do not exceed 2 times of normal value\n\n          -  Can comply with study protocol\n\n        Exclusion Criteria:\n\n          -  Have allergic history of any tested compounds\n\n          -  Fever from other causes, not by URI\n\n          -  Take any herbal medicines during 2 weeks before enrollment\n\n          -  Physicians decide to withdraw the subjects with any reasons"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01958866", 
            "org_study_id": "0156"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tinospora Crispa-extract Product", 
                "intervention_name": "Tinospora Crispa-extract Product", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Acetaminophen", 
                "intervention_name": "Acetaminophen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Fever", 
            "Body temperature"
        ], 
        "lastchanged_date": "October 7, 2013", 
        "location": {
            "contact": {
                "last_name": "Pornanong Aramwit, PharmD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10330"
                }, 
                "name": "Pornanong Aramwit"
            }, 
            "investigator": {
                "last_name": "Pornanong Aramwit, PharmD,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "aramwit@gmail.com", 
            "last_name": "Pornanong Aramwit", 
            "phone": "+66899217255"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Body Temperature", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline in temperature at 1, 2, 3, 4, 6, 8, 12 and 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01958866"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chulalongkorn University", 
            "investigator_full_name": "Pornanong Aramwit, Pharm.D., Ph.D", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Liver and kidney function will be randomly evaluated. Number of participants with soft stool will be recorded.", 
            "measure": "Number of adverse events: diarrhea, elevated liver enzyme and elevated creatinine", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for the duration of hospital stay (24 hours)"
        }, 
        "source": "Chulalongkorn University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chulalongkorn University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}